View of Comparative Effectiveness and Safety of Systemic Versus Intralesional Bevacizumab in the Management of Recurrent Respiratory Papillomatosis
Return to Article Details Comparative Effectiveness and Safety of Systemic Versus Intralesional Bevacizumab in the Management of Recurrent Respiratory Papillomatosis Download Download PDF